Treatment Reduces Diabetes Risk in People With Rheumatoid Arthritis

From the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), February 2008.

"Antirheumatic, Antimalarial Treatment Reduces Diabetes Risk in People With Rheumatoid Arthritis":

Researchers partly funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) recently found that hydroxychloroquine, a medication used to treat rheumatic diseases and malaria, reduced the incidence of diabetes in people with rheumatoid arthritis (RA). RA is an inflammatory disease that causes pain, swelling, stiffness and loss of function in the joints.

For the full article, see http://www.niams.nih.gov/News_and_Events/Spotlight_on_Research/2008/Diabetes_RA.asp

bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark

Related posts

Print This Post Print This Post Email This Post Email This Post


Leave your comments

You must be logged in to post a comment.

|Top | Content|

  • Running Time

    From February 1, 2008 to August 17, 2008 Started 212  

|Top | FarBar|



Attention: This is the end of the usable page!
The images below are preloaded standbys only.
This is helpful to those with slower Internet connections.